Philip W. Jenkinson
Edinburgh, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohn's disease.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: July 12, 2022
Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: a retrospective prevalent cohort analysis.
Journal: Alimentary pharmacology & therapeutics
Published: November 05, 2021
Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts.
Journal: Journal of Crohn's & colitis
Published: June 05, 2021
Temporal Trends in Surgical Resection Rates and Biologic Prescribing in Crohn's Disease: A Population-based Cohort Study.
Journal: Journal of Crohn's & colitis
Published: August 26, 2020
Analysis of colectomy rates for ulcerative colitis in pre- and postbiological eras in Lothian, Scotland.
Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
Published: July 06, 2020
Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort.
Journal: Journal of gastroenterology and hepatology
Published: June 05, 2020
The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis.
Journal: Inflammatory bowel diseases
Published: January 07, 2020
Colon capsule endoscopy.
Journal: The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
Published: December 17, 2019
Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn's Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: November 11, 2019
Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease.
Journal: European journal of gastroenterology & hepatology
Published: October 01, 2019
IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology.
Journal: Gut
Published: April 22, 2019
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort.
Journal: Journal of Crohn's & colitis
Published: February 16, 2019
Last Updated: 09/26/2026